Back to mobile site

Inogen (INGN) Raises Revenue Guidance Following 3Q Beat; Needham & Company Reiterates Strong Buy

November 11, 2015 7:02 AM EST Send to a Friend
Needham & Company reiterated a Strong Buy rating on Inogen, Inc (NASDAQ: INGN), and raised the price target to $55.00 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login